We are a drug company specializing on stroke recovery medicines, and the only accredited distributor of FDA-approved NeuroAID II MLC 901 in the Philippines.
As a company in the healthcare industry, we commit to building stronger and healthier communities by improving human services and support systems, especially for those who need them most.
We are looking for self-driven people with a great ambition to be a part of a new market innovation that will introduce the Traditional Chinese Medicine concept that is evidence-based medicine compliant.
E* Chi’mes proudly participated in the Mingfule Round Table Discussion held at Olivia’s Pizzeria, Pangasinan . The event brought together healthcare professionals to discuss the latest updates, strategies, and insights on the use of Mingfule, fostering collaboration and knowledge-sharing among participants. The discussion encouraged open dialogue, sharing of experiences, and practical insights, allowing attendees to deepen their understanding and optimize patient care with M
E* Chi’mes proudly participated in the 2025 PNA Neurology Week , headed by Dr. Marietta Olaivar , and held at Marikina Cathedral School . The event brought together students, educators, and healthcare advocates for an engaging and educational program focused on neurological health and brain wellness. Throughout the activity, students enjoyed interactive lectures and hands-on learning sessions designed to help them understand the importance of taking care of the brain, recogni
E* Chi’mes is honored to support an educational program at Ciudad Medical Zamboanga Hospital , focusing on the critical topic “Tenecteplase for Thrombolysis in Acute Ischemic Stroke.” This activity aims to enhance clinical knowledge, promote best practices, and strengthen stroke management across healthcare teams. The session featured Dr. Kalbi Muktader as the distinguished speaker, who shared valuable insights on the role of Tenecteplase in acute ischemic stroke, current t
